Zydus Lifesciences Limited has informed the Exchange about General Updates
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences has informed exchanges that Auroralux S.A.S., a Luxembourg-based step-down wholly owned subsidiary (held through Zydus MedTech France), has been dissolved without liquidation effective December 31, 2025. As a result of the dissolution, all assets and liabilities of Auroralux, including its investment in Amplitude Surgical S.A.S., have been transferred to Zydus MedTech (France) S.A.S. Consequently, Amplitude Surgical has become a direct wholly owned subsidiary of Zydus MedTech (France). The company has stated that this restructuring will not impact its business operations.
This is a purely internal corporate restructuring with no change in Zydus Lifesciences' ultimate ownership of its foreign subsidiaries and no expected impact on business or financials. Shareholders are unlikely to see any material effect on the stock from this announcement.